AI assistant
Sending…
BIO-TECHNE Corp — Director's Dealing 2014
Aug 14, 2014
30718_dirs_2014-08-14_3f09d57b-22d7-4f09-a6ad-803f585325a8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2014-08-12
Reporting Person: Furlow Brenda S. (SVP - General Counsel)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-08-12 | Stock Option (Right to Buy) | $94.35 | A | 15000 | Acquired | 2021-08-12 | Common Stock (15000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2500 | Direct |
Footnotes
F1: Includes 2,500 restricted stock units that represent a contingent right to receive one share of Techne Corporation common stock. The restricted stock units vest subject to certain conditions beginning July 1, 2015 and annually thereafter, in a total of three equal installments. Shares will be delivered to the reporting person following vesting.
F2: Vests 3,750 on each of 8/12/15, 8/12/16, 8/12/17, and 8/12/18.
More from BIO-TECHNE Corp
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 19
Board/Management Information
2026
Feb 11
Director's Dealing
2026
Feb 5
Interim / Quarterly Report
2026
Feb 4